Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Drazner

Showing results (61-70 of 290) with videos related to

Pageof 29
Sort By:
Heart Failure Clinics|July 28, 2009
Newer biomarkers in heart failureSachin Gupta, Mark H Drazner, James A de Lemos
JACC. Heart Failure|October 11, 2014
Reply: Bendopnea and pseudobendopneaJennifer T Thibodeau, Benjamin D Levine, Mark H Drazner
JACC. Heart Failure|July 16, 2014
Factors influencing the rate of flow through continuous-flow left ventricular assist devices at rest and with exerciseBenjamin D Levine, William K Cornwell, Mark H Drazner
The American Journal of Medicine|May 3, 2003
Third heart sound and elevated jugular venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunctionMark H Drazner, J Eduardo Rame, Daniel L Dries
JACC. Heart Failure|September 19, 2025
GLP-1 Receptor Agonists in Heart Failure With Reduced Ejection Fraction?: Faster Heart Rate, So Not So FastSheldon E Litwin, Mark H Drazner, Andrea M Russo
JACC. Heart Failure|August 9, 2014
Reply: "Bendopnea" or "kamptopnea?": Some thoughts on terminology and mechanismsJennifer T Thibodeau, Benjamin D Levine, Mark H Drazner
Journal of Cardiac Failure|August 3, 2024
The Impact of Kinlessness on Older Adults with Advanced Heart FailureSarah Godfrey, Jennifer Nixon, Mark H Drazner, et al.
Journal of Cardiac Failure|April 8, 2026
Importance of the Physiological Examination in Cardiogenic ShockFaris Araj, Anas Jawaid, Mark H Drazner, et al.
Lancet (London, England)|August 2, 2003
B-type natriuretic peptide in cardiovascular diseaseJames A de Lemos, Darren K McGuire, Mark H Drazner
Herz|June 24, 2008
Cardiomyopathy in type 2 diabetes: update on pathophysiological mechanismsJustin Saunders, Shiny Mathewkutty, Mark H Drazner, et al.
Pageof 29

Showing results (61-70 of 290) with videos related to

Sort By:
Pageof 29
Heart Failure Clinics|July 28, 2009
Newer biomarkers in heart failureSachin Gupta, Mark H Drazner, James A de Lemos
JACC. Heart Failure|October 11, 2014
Reply: Bendopnea and pseudobendopneaJennifer T Thibodeau, Benjamin D Levine, Mark H Drazner
JACC. Heart Failure|July 16, 2014
Factors influencing the rate of flow through continuous-flow left ventricular assist devices at rest and with exerciseBenjamin D Levine, William K Cornwell, Mark H Drazner
The American Journal of Medicine|May 3, 2003
Third heart sound and elevated jugular venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunctionMark H Drazner, J Eduardo Rame, Daniel L Dries
JACC. Heart Failure|September 19, 2025
GLP-1 Receptor Agonists in Heart Failure With Reduced Ejection Fraction?: Faster Heart Rate, So Not So FastSheldon E Litwin, Mark H Drazner, Andrea M Russo
JACC. Heart Failure|August 9, 2014
Reply: "Bendopnea" or "kamptopnea?": Some thoughts on terminology and mechanismsJennifer T Thibodeau, Benjamin D Levine, Mark H Drazner
Journal of Cardiac Failure|August 3, 2024
The Impact of Kinlessness on Older Adults with Advanced Heart FailureSarah Godfrey, Jennifer Nixon, Mark H Drazner, et al.
Journal of Cardiac Failure|April 8, 2026
Importance of the Physiological Examination in Cardiogenic ShockFaris Araj, Anas Jawaid, Mark H Drazner, et al.
Lancet (London, England)|August 2, 2003
B-type natriuretic peptide in cardiovascular diseaseJames A de Lemos, Darren K McGuire, Mark H Drazner
Herz|June 24, 2008
Cardiomyopathy in type 2 diabetes: update on pathophysiological mechanismsJustin Saunders, Shiny Mathewkutty, Mark H Drazner, et al.
Pageof 29